HaloTag7 self-labelling protein tag followed by a TEV protease site (Halo-TEV)
HaloTag7, a 307-residue engineered haloalkane dehalogenase that forms a covalent bond with chloroalkane ligands, followed by a TEV protease site. The covalent bond lets one tag accept any Halo ligand, so the same construct can be imaged with a fluorophore or captured on resin, then released by TEV cleavage.
| Origin | Engineered haloalkane dehalogenase (HaloTag7) with a C-terminal TEV site |
|---|---|
| Cleavable | Yes |
| Uses | labeling, purification |
| Detection Reagents | HaloTag chloroalkane ligands, HaloLink resin, anti-HaloTag antibody |
Characteristics
921 nucleotides encoding 307 amino acids in frame, ending EDLYFQS, a TEV protease site. HaloTag7 reacts covalently and irreversibly with a chloroalkane ligand, so labelling is stoichiometric and does not wash out, unlike an antibody-based or affinity interaction. The same protein therefore serves for fluorescent imaging, pull-down, or immobilization depending only on which ligand is supplied. The appended site uses serine at the P1' position (EDLYFQS) rather than the glycine of the canonical ENLYFQG.
Applications
Covalent fluorescent labelling for live-cell and fixed imaging, pull-down on chloroalkane resin, and immobilization, from one tagged construct. The TEV site releases the cargo from resin-bound tag after capture.
Limitations
At 921 nucleotides it is a large tag, comparable to a fluorescent protein, so it consumes real payload budget in a size-constrained vector and can perturb a small fusion partner. Labelling needs a cell-permeable chloroalkane ligand supplied separately. TEV cleavage leaves one residue of the site on the released protein.
Sequence921 bp
Sign in to view the full sequence.
Sign inReferences
- 1.Ohana et al. (2009). HaloTag7: A genetically engineered tag that enhances bacterial expression of soluble proteins and improves protein purification. Protein Expr Purif — Ohana 2009 HaloTag7
